SREBF2 and metabolic dysfunction-associated steatotic liver disease: In the present study, we demonstrated that mice with Dscr-1 null mutation exhibited SREBP2 hyperactivation and susceptibility to oxidative or ER stresses and eventually developed NAFLD.